Xie D - Search Results

1

DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis.

Xie D, Gore C, Zhou J, Pong RC, Zhang H, Yu L, Vessella RL, Min W, Hsieh JT. Xie D, et al. Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):19878-83. doi: 10.1073/pnas.0908458106. Epub 2009 Nov 10. Proc Natl Acad Sci U S A. 2009. PMID: 19903888 Free PMC article.

2

DAB2IP in cancer.

Liu L, Xu C, Hsieh JT, Gong J, Xie D. Liu L, et al. Among authors: xie d. Oncotarget. 2016 Jan 26;7(4):3766-76. doi: 10.18632/oncotarget.6501. Oncotarget. 2016. PMID: 26658103 Free PMC article. Review.

3

Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis.

Xie D, Gore C, Liu J, Pong RC, Mason R, Hao G, Long M, Kabbani W, Yu L, Zhang H, Chen H, Sun X, Boothman DA, Min W, Hsieh JT. Xie D, et al. Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2485-90. doi: 10.1073/pnas.0908133107. Epub 2010 Jan 13. Proc Natl Acad Sci U S A. 2010. PMID: 20080667 Free PMC article.

4

Downregulation of human DAB2IP gene expression in prostate cancer cells results in resistance to ionizing radiation.

Kong Z, Xie D, Boike T, Raghavan P, Burma S, Chen DJ, Habib AA, Chakraborty A, Hsieh JT, Saha D. Kong Z, et al. Among authors: xie d. Cancer Res. 2010 Apr 1;70(7):2829-39. doi: 10.1158/0008-5472.CAN-09-2919. Epub 2010 Mar 23. Cancer Res. 2010. PMID: 20332235

5

Epothilone B confers radiation dose enhancement in DAB2IP gene knock-down radioresistant prostate cancer cells.

Kong Z, Raghavan P, Xie D, Boike T, Burma S, Chen D, Chakraborty A, Hsieh JT, Saha D. Kong Z, et al. Among authors: xie d. Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1210-8. doi: 10.1016/j.ijrobp.2010.06.019. Int J Radiat Oncol Biol Phys. 2010. PMID: 20970033

6

The mechanism of DAB2IP in chemoresistance of prostate cancer cells.

Wu K, Xie D, Zou Y, Zhang T, Pong RC, Xiao G, Fazli L, Gleave M, He D, Boothman DA, Hsieh JT. Wu K, et al. Among authors: xie d. Clin Cancer Res. 2013 Sep 1;19(17):4740-9. doi: 10.1158/1078-0432.CCR-13-0954. Epub 2013 Jul 9. Clin Cancer Res. 2013. PMID: 23838317 Free PMC article.

7

The role of DAB2IP in androgen receptor activation during prostate cancer progression.

Wu K, Liu J, Tseng SF, Gore C, Ning Z, Sharifi N, Fazli L, Gleave M, Kapur P, Xiao G, Sun X, Oz OK, Min W, Alexandrakis G, Yang CR, Hsieh CL, Wu HC, He D, Xie D, Hsieh JT. Wu K, et al. Among authors: xie d. Oncogene. 2014 Apr 10;33(15):1954-63. doi: 10.1038/onc.2013.143. Epub 2013 Apr 22. Oncogene. 2014. PMID: 23604126

8

DAB2IP regulates cancer stem cell phenotypes through modulating stem cell factor receptor and ZEB1.

Yun EJ, Baek ST, Xie D, Tseng SF, Dobin T, Hernandez E, Zhou J, Zhang L, Yang J, Sun H, Xiao G, He D, Kittler R, Hsieh JT. Yun EJ, et al. Among authors: xie d. Oncogene. 2015 May 21;34(21):2741-52. doi: 10.1038/onc.2014.215. Epub 2014 Jul 21. Oncogene. 2015. PMID: 25043300

9

SPAG5 promotes proliferation and suppresses apoptosis in bladder urothelial carcinoma by upregulating Wnt3 via activating the AKT/mTOR pathway and predicts poorer survival.

Liu JY, Zeng QH, Cao PG, Xie D, Yang F, He LY, Dai YB, Li JJ, Liu XM, Zeng HL, Fan XJ, Liu L, Zhu YX, Gong L, Cheng Y, Zhou JD, Hu J, Bo H, Xu ZZ, Cao K. Liu JY, et al. Among authors: xie d. Oncogene. 2018 Jul;37(29):3937-3952. doi: 10.1038/s41388-018-0223-2. Epub 2018 Apr 17. Oncogene. 2018. PMID: 29662193

10

Absence of DAB2IP promotes cancer stem cell like signatures and indicates poor survival outcome in colorectal cancer.

Min J, Liu L, Li X, Jiang J, Wang J, Zhang B, Cao D, Yu D, Tao D, Hu J, Gong J, Xie D. Min J, et al. Among authors: xie d. Sci Rep. 2015 Nov 13;5:16578. doi: 10.1038/srep16578. Sci Rep. 2015. PMID: 26564738 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,122 results

Search Page